Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) revealed a profit for first quarter that Dropped, from the same period last year
The company's bottom line totaled RMB172.084 million, or RMB0.19 per share. This compares with RMB250.202 million, or RMB0.28 per share, last year.
The company's revenue for the period fell 19.5% to RMB1.200 billion from RMB1.490 billion last year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB172.084 Mln. vs. RMB250.202 Mln. last year.-EPS: RMB0.19 vs. RMB0.28 last year.-Revenue: RMB1.200 Bln vs. RMB1.490 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.